Literature DB >> 31694758

Ebola virus replication is regulated by the phosphorylation of viral protein VP35.

Lin Zhu1, Ting Gao2, Weihong Yang2, Yaoning Liu2, Xuan Liu2, Yong Hu2, Yanwen Jin2, Ping Li2, Ke Xu3, Gang Zou4, Lei Zhao5, Ruiyuan Cao5, Wu Zhong5, Xianzhu Xia6, Cheng Cao7.   

Abstract

Ebola virus (EBOV) is a zoonotic pathogen, the infection often results in severe, potentially fatal, systematic disease in human and nonhuman primates. VP35, an essential viral RNA-dependent RNA polymerase cofactor, is indispensable for Ebola viral replication and host innate immune escape. In this study, VP35 was demonstrated to be phosphorylated at Serine/Threonine by immunoblotting, and the major phosphorylation sites was S187, S205, T206, S208 and S317 as revealed by LC-MS/MS. By an EBOV minigenomic system, EBOV minigenome replication was shown to be significantly inhibited by the phosphorylation-defective mutant, VP35 S187A, but was potentiated by the phosphorylation mimic mutant VP35 S187D. Together, our findings demonstrate that EBOV VP35 is phosphorylated on multiple residues in host cells, especially on S187, which may contribute to efficient viral genomic replication and viral proliferation.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  EBOV replication; Minigenome; Phosphorylation; S187; VP35

Mesh:

Substances:

Year:  2019        PMID: 31694758     DOI: 10.1016/j.bbrc.2019.10.147

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  A Comparative NLP-Based Study on the Current Trends and Future Directions in COVID-19 Research.

Authors:  Priyankar Bose; Satyaki Roy; Preetam Ghosh
Journal:  IEEE Access       Date:  2021-05-20       Impact factor: 3.367

2.  Ubiquitination of Ebola virus VP35 at lysine 309 regulates viral transcription and assembly.

Authors:  Sarah van Tol; Birte Kalveram; Philipp A Ilinykh; Adam Ronk; Kai Huang; Leopoldo Aguilera-Aguirre; Preeti Bharaj; Adam Hage; Colm Atkins; Maria I Giraldo; Maki Wakamiya; Maria Gonzalez-Orozco; Abbey N Warren; Alexander Bukreyev; Alexander N Freiberg; Ricardo Rajsbaum
Journal:  PLoS Pathog       Date:  2022-05-09       Impact factor: 7.464

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.